Investigating <scp>HER2</scp>‐Low in Early Breast Cancer: Prognostic Implications and Age‐Related Prognostic Stratification
This extensive retrospective study demonstrates that HER2-low status cannot serve as an independent prognostic factor in the entire cohort, nor in the HR-positive and HR-negative groups individually. However, the combined factors of HER2-low status and age may indicate a potential contribution to the prognostic stratification of TNBC.
Authors
- E Chen (ORCID: https://orcid.org/0009-0000-9748-8388)
- Xiaoqu Hu (ORCID: https://orcid.org/0000-0002-4140-1252)
- Chen Chen (ORCID: https://orcid.org/0009-0009-3940-1569)
- Yingying Chen (ORCID: https://orcid.org/0000-0001-9162-1467)
- Nan Chen (ORCID: https://orcid.org/0000-0001-8210-103X)
- Quan Li (ORCID: https://orcid.org/0009-0000-2213-3443)
- Jie You (ORCID: https://orcid.org/0000-0002-4657-6377)
- Qingxuan Wang (ORCID: https://orcid.org/0000-0001-7085-4472)
- Yefeng Cai (ORCID: https://orcid.org/0009-0009-3177-271X)
- S. W. Xu (ORCID: https://orcid.org/0000-0003-0383-5604)
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1002/cam4.70637
- Citations
- 2
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- Wenzhou Medical University
- Science and Technology Plan Project of Wenzhou, China